- Filed
- May 6, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $76.3M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $0 |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $110.9M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $111.41M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $433.11M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $360.03M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $251.28M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $205.38M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $855.98M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $803.76M |
| Sga Expense | Q1 2025 · Mar 31, 2025 | $38.63M |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $34.23M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 104.68M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $21.07M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$14.08M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $175.05M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2023 | $208.67M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $25.68M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | −$160.59M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.09 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.09 |
| Net Income | Q1 2025 · Mar 31, 2024 | −$9.83M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$32.37M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $6.84M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $48.32M |
| Revenue | Q1 2025 · Mar 31, 2024 | $55.16M |